Skip to content

Influence of nucleotide on muscle atrophy

Influence of nucleotide on muscle atrophy - Influence of nucleotide on muscle atrophy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000045069
Enrollment
24
Registered
2021-08-10
Start date
2021-08-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subject

Interventions

Sponsors

Juntendo University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) BMI of less than 30 kg/m2 (2) Must be in good physical condition and able to perform the test safely (3) Those who voluntarily participate in the test with written consent

Exclusion criteria

Exclusion criteria: (1) Those who have metal or other objects in their body that prevent them from performing MRI measurements. (2) Those who routinely perform upper limb training. (3) Patients with glucose metabolism disorder, endocrine disorder, kidney, liver, or digestive organ disease. (4) Patients undergoing medical treatment by a physician. (5) Those who have been diagnosed as suffering from heart disease. (6) Patients with type I or type II diabetes (7) Those who have been diagnosed as requiring treatment or re-examination at a medical check-up within the past year (8) Those who participated in another clinical trial within the last 3 months (9) Those who have used illicit drugs in the last 6 months. (10) Patients who have had alcoholism or drug addiction in the last 6 months

Design outcomes

Primary

MeasureTime frame
muscle atrophy

Countries

Japan

Contacts

Public ContactAtsushi Kubota

Juntendo University Graduate School of Health and Sports Science

akubota@juntendo.ac.jp+81476981001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026